NCT06546319Completed
Music Therapy to Address Patients' Journeys With Chronic Illness, Outcomes, and Readmission - MAJOR CHORD RCT
Music Therapy to Address Patients' Journeys With Chronic Illness, Outcomes, and Readmission (MAJOR CHORD RCT): A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 6 Aug 2025
Brief summary (registry, in English)
Conduct a randomized trial (n = 60: with n = 30 receiving music therapy and n = 30 receiving usual care) to investigate the feasibility, acceptability, and preliminary efficacy of the MAJOR CHORD music therapy intervention compared to usual care on (a) health-related quality of life (e.g., physical function, depression, anxiety, fatigue, and pain interference), (b) perceived stress, (c) self-efficacy, and (d) 30-day readmission rates
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 6 Aug 2024
- Start date
- 26 Aug 2024
- Primary completion date
- 17 Jun 2025
- Lead sponsor
- Samuel Rodgers-Melnick
- Diseases
- Heart failure, COPD
- NCT number
- NCT06546319
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 26 Aug 2024 to the primary completion date, 17 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Included on the Music Therapy Referral patient list in the EHR
- Receiving active cancer treatment (e.g., chemotherapy, radiation, immunotherapy) as documented in EHR
- Receiving hospice care as documented in EHR
- Has end stage renal disease or is currently receiving dialysis
- Qualitative Interview Exclusion Criteria
- 1\. Randomized to the control arm
Other illness
- Active confirmed or suspected COVID-19, or under droplet, contact, MRSA, and/or C.diff precaution notification as documented in the EHR
- Significant hearing and/or visual impairment as documented in EHR
- Diagnosed with medical condition likely to be terminal within 24 weeks as documented in EHR
- On wait list for heart transplantation or ventricular assist device (VAD) as documented in EHR
Other
- Unable to independently provide consent (i.e., no proxy consent)
- Active suicidal ideation as documented in EHR during current hospital admission
- Severe psychological comorbidity (e.g., psychosis, schizophrenia) that would prevent patient from engaging fully in intervention as documented in EHR
- NYHA Stage IV HF or end-stage COPD as documented in EHR
- Active substance abuse as documented in EHR
Who the study is looking for
- Age range: ≥30 to ≤89 years
- Primary indication for current hospitalization is either COPD or HF with confirmed ICD-10 code in the electronic health record (EHR)
- Able to read and understand English
- Hospitalized at UH Cleveland Medical Center (UHCMC) with anticipated length of stay following recruitment ≥ 2 days as documented in electronic health record (EHR) and confirmed by the clinical care team
- Access to Wi-Fi, active email address, \& laptop, tablet, smartphone, and/or PC with videoconferencing capabilities at home or the facility in which they will be discharged
- Has reliable access to a mobile device with an active data plan at the hospital and at home and is comfortable accessing the internet and their email with this device
- Qualitative Interview Inclusion Criteria 1. Agreed to be contacted for the qualitative interview during contenting process for the RCT
Criteria the registry did not label
- Randomized Control Trial
Age in the registry: 30 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospitals Cleveland Medical Center* Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.